查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
富血小板血漿(PRP)市場 - 成長，未來展望，競爭分析，2023年～2031年
市場調查報告書
商品編碼
1293851

富血小板血漿(PRP)市場 - 成長，未來展望，競爭分析，2023年～2031年

Platelet Rich Plasma (PRP) Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2031 年，富血小板血漿 (PRP) 市場將增長 14.5%。富血小板血漿（PRP）是在少量血漿中含有大量血小板的產品。PRP 作為纖維蛋白組織粘合劑，具有組織密封和止血特性。PRP 不同於貧血小板組織和纖維蛋白膠，因為它具有增強傷口癒合過程和骨形成的獨特能力。PRP 作為一種安全、生物相容且快速的止血劑，可加速表皮、上皮和內皮的再生。PRP 促進膠原蛋白合成，促進血管生成，減少真皮疤痕，增強軟組織癒合，並逆轉糖皮質激素對癒合的抑制。PRP 中含有的高濃度白細胞可提供額外的抗菌作用。

PRP 用於廣泛的臨床治療應用，包括耳鼻喉科、普通外科、美容和美容外科、燒傷和傷口癒合、心血管外科以及口腔頜面外科。PRP 已被證明可以有效治療慢性不癒合傷口，並且還被用作血管生成抑製劑。在手術中，PRP 可以降低供體和受體部位的術後和術前出血風險，增強軟組織癒合，並增強受體部位移植組織的粘附性和內聚性，促進穩定性。

目錄

第1章 序文

  • 報告內容
    • 報告書的目的
    • 主要讀者
    • 主要的提供商品
  • 市場區隔
  • 調查手法

第2章 摘要整理

第3章 富血小板血漿(PRP)市場:競爭分析

  • 主要供應商的市場地位
  • 供應商採用的策略
  • 主要的產業策略
  • 層級分析:2022 vs 2031

第4章 富血小板血漿(PRP)市場:常量分析和市場動態

  • 簡介
  • 全球富血小板血漿(PRP)市場金額 2021-2031
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響分析
  • Seesaw分析

第5章 富血小板血漿(PRP)市場:各類型 2021-2031

  • 市場概要
  • 成長·收益分析:2022 vs 2031
  • 市場區隔
    • 純粹PRP
    • 大量地含有白血球的PRP
    • 其他

第6章 富血小板血漿(PRP)市場:各用途 2021-2031

  • 市場概要
  • 成長·收益分析:2022 vs 2031
  • 市場區隔
    • 整形外科
    • 運動醫學
    • 美容整形
    • 皮膚科
      • 潰瘍的治癒
      • 其他
    • 眼科手術
    • 腦神經外科
    • 一般外科
    • 其他

第7章 富血小板血漿(PRP)市場:各最終用途 2021-2031

  • 市場概要
  • 成長·收益分析:2022 vs 2031
  • 市場區隔
    • 醫院
    • 診所
    • 其他

第8章 北美的富血小板血漿(PRP)市場 2021-2031

  • 市場概要
  • 富血小板血漿(PRP)市場:各類型 2021-2031
  • 富血小板血漿(PRP)市場:各用途 2021-2031
  • 富血小板血漿(PRP)市場:各最終用途 2021-2031
  • 富血小板血漿(PRP)市場:各地區 2021-2031
    • 北美
      • 美國
      • 加拿大
      • 其他北美地區

第9章 英國·歐洲聯盟的富血小板血漿(PRP)市場 2021-2031

  • 市場概要
  • 富血小板血漿(PRP)市場:各類型 2021-2031
  • 富血小板血漿(PRP)市場:各用途 2021-2031
  • 富血小板血漿(PRP)市場:各最終用途 2021-2031
  • 富血小板血漿(PRP)市場:各地區 2021-2031
    • 英國·歐洲聯盟
      • 英國
      • 德國
      • 西班牙
      • 義大利
      • 法國
      • 其他歐洲地區

第10章 亞太地區的富血小板血漿(PRP)市場 2021-2031

  • 市場概要
  • 富血小板血漿(PRP)市場:各類型 2021-2031
  • 富血小板血漿(PRP)市場:各用途 2021-2031
  • 富血小板血漿(PRP)市場:各最終用途 2021-2031
  • 富血小板血漿(PRP)市場:各地區 2021-2031
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 其他亞太地區

第11章 南美的富血小板血漿(PRP)市場 2021-2031

  • 市場概要
  • 富血小板血漿(PRP)市場:各類型 2021-2031
  • 富血小板血漿(PRP)市場:各用途 2021-2031
  • 富血小板血漿(PRP)市場:各最終用途 2021-2031
  • 富血小板血漿(PRP)市場:各地區 2021-2031
    • 南美
      • 巴西
      • 墨西哥
      • 其他南美國家地區

第12章 中東·非洲的富血小板血漿(PRP)市場 2021-2031

  • 市場概要
  • 富血小板血漿(PRP)市場:各類型 2021-2031
  • 富血小板血漿(PRP)市場:各用途 2021-2031
  • 富血小板血漿(PRP)市場:各最終用途 2021-2031
  • 富血小板血漿(PRP)市場:各地區 2021-2031
    • 中東·非洲
      • GCC
      • 非洲
      • 其他中東·非洲地區

第13章 企業簡介

  • Johnson & Johnson Services Inc.
  • Arthrex Inc.
  • EmCyte Corporation
  • Dr PRP USA LLC
  • Juventix Regenerative Medical LLC.
  • Terumo Corporation
  • Zimmer Biomet
  • Stryker
  • Apex Biologix
  • Celling Biosciences Inc.
Product Code: 137082-05-23

Platelet Rich Plasma (PRP) Market is Expected to Grow at 14.5% by 2031. Platelet rich plasma (PRP) is a product that contains large number of platelets in a small plasma volume. PRP works as a fibrin tissue adhesive with tissue sealing and hemostatic characteristics. PRP differs from platelet-poor tissue and fibrin glue because PRP provides a unique ability to augment wound healing process and osteogenesis. PRP functions as a safe, biocompatible prompt hemostatic agent and fast-tracks epidermal, epithelial and endothelial regeneration. PRP enhances collagen synthesis, encourages angiogenesis, reduces dermal scarring, augments soft tissue healing and reverses inhibition of glucocorticoid would healing. High concentration of leukocyte in PRP offers additional antimicrobial effect.

PRP offers a wide range of clinical healing uses in otolaryngology, general surgery, cosmetic surgery and aesthetics, burn and would healing, cardiovascular surgery, oral and maxillofacial surgical procedures and others. PRP has proven effectiveness in treating chronic non-healing wounds and has been adopted as antiangiogenic agent. In surgical procedures, PRP reduces the risk of postoperative and preoperative bleeding both at donor and recipient sites; it augments soft tissue healing and facilitates stability to grafted tissue at the recipient site owing to its adhesive and cohesive properties.

Key players identified for platelet rich plasma market include but are not limited to:

  • Johnson & Johnson Services, Inc.
  • Arthrex, Inc.
  • EmCyte Corporation
  • Dr PRP USA LLC
  • Juventix Regenerative Medical, LLC.
  • Terumo Corporation
  • Zimmer Biomet
  • Stryker
  • Apex Biologix
  • Celling Biosciences, Inc.

Historical & Forecast Period

This study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Platelet Rich Plasma (PRP) market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Platelet Rich Plasma (PRP) market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approaches for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Segmentation

Type

  • Pure Platelet Rich Plasma
  • Leukocyte Rich Platelet Rich Plasma
  • Others

Application

  • Orthopedics
  • Sports Medicine
  • Cosmetic Surgery
  • Dermatology
    • Ulcer Healing
      • Venous Ulcer
      • Traumatic Ulcer
      • Diabetic Ulcer
      • Pyoderma Gangrenosum Ulcer
      • Trophic Ulcer
      • Vasculitic Ulcer
      • Others
    • Others
  • Ophthalmic Surgery
  • Neurosurgery
  • General Surgery
  • Others

End-use

  • Hospitals
  • Clinics
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Platelet Rich Plasma (PRP) market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Platelet Rich Plasma (PRP) market?
  • Which is the largest regional market for Platelet Rich Plasma (PRP) market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Platelet Rich Plasma (PRP) market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Platelet Rich Plasma (PRP) market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Platelet Rich Plasma (PRP) Market
  • 2.2. Global Platelet Rich Plasma (PRP) Market, By Type, 2022 (US$ Million)
  • 2.3. Global Platelet Rich Plasma (PRP) Market, By Application, 2022 (US$ Million)
  • 2.4. Global Platelet Rich Plasma (PRP) Market, By End-use, 2022 (US$ Million)
  • 2.5. Global Platelet Rich Plasma (PRP) Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Platelet Rich Plasma (PRP) Market: Competitive Analysis

  • 3.1. Market Positioning of Key Platelet Rich Plasma (PRP) Market Vendors
  • 3.2. Strategies Adopted by Platelet Rich Plasma (PRP) Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Platelet Rich Plasma (PRP) Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Platelet Rich Plasma (PRP) Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Pure Platelet Rich Plasma
    • 5.3.2. Leukocyte Rich Platelet Rich Plasma
    • 5.3.3. Others

6. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Orthopedics
    • 6.3.2. Sports Medicine
    • 6.3.3. Cosmetic Surgery
    • 6.3.4. Dermatology
      • 6.3.4.1. Ulcer Healing
        • 6.3.4.1.1. Venous Ulcer
        • 6.3.4.1.2. Traumatic Ulcer
        • 6.3.4.1.3. Diabetic Ulcer
        • 6.3.4.1.4. Pyoderma Gangrenosum Ulcer
        • 6.3.4.1.5. Trophic Ulcer
        • 6.3.4.1.6. Vasculitic Ulcer
        • 6.3.4.1.7. Others
      • 6.3.4.2. Others
    • 6.3.5. Ophthalmic Surgery
    • 6.3.6. Neurosurgery
    • 6.3.7. General Surgery
    • 6.3.8. Others

7. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Others

8. North America Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 8.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 8.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 8.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

9. UK and European Union Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 9.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 9.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 9.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.4.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.4.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.5.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.5.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.6.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.6.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

10. Asia Pacific Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 10.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 10.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 10.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.4.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.4.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.5.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.5.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.6.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.6.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

11. Latin America Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 11.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 11.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 11.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

12. Middle East and Africa Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 12.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 12.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 12.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Johnson & Johnson Services, Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Arthrex, Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. EmCyte Corporation
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Dr PRP USA LLC
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Juventix Regenerative Medical, LLC.
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Terumo Corporation
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Zimmer Biomet
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Stryker
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Apex Biologix
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Celling Biosciences, Inc.
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 2 Global Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 3 Global Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 4 Global Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 5 Global Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 6 North America Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 7 North America Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 8 North America Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 9 North America Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 10 North America Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 11 U.S. Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 12 U.S. Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 13 U.S. Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 14 U.S. Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 15 U.S. Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 16 Canada Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 17 Canada Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 18 Canada Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 19 Canada Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 20 Canada Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 21 Rest of North America Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 22 Rest of North America Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 23 Rest of North America Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 24 Rest of North America Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 25 Rest of North America Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 26 UK and European Union Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 27 UK and European Union Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 28 UK and European Union Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 29 UK and European Union Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 30 UK and European Union Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 31 UK Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 32 UK Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 33 UK Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 34 UK Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 35 UK Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 36 Germany Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 37 Germany Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 38 Germany Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 39 Germany Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 40 Germany Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 41 Spain Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 42 Spain Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 43 Spain Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 44 Spain Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 45 Spain Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 46 Italy Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 47 Italy Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 48 Italy Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 49 Italy Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 50 Italy Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 51 France Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 52 France Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 53 France Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 54 France Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 55 France Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 56 Rest of Europe Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 57 Rest of Europe Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 58 Rest of Europe Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 59 Rest of Europe Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 60 Rest of Europe Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 61 Asia Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 62 Asia Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 63 Asia Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 64 Asia Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 65 Asia Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 66 China Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 67 China Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 68 China Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 69 China Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 70 China Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 71 Japan Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 72 Japan Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 73 Japan Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 74 Japan Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 75 Japan Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 76 India Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 77 India Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 78 India Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 79 India Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 80 India Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 81 Australia Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 82 Australia Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 83 Australia Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 84 Australia Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 85 Australia Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 86 South Korea Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 87 South Korea Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 88 South Korea Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 89 South Korea Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 90 South Korea Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 91 Latin America Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 92 Latin America Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 93 Latin America Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 94 Latin America Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 95 Latin America Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 96 Brazil Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 97 Brazil Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 98 Brazil Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 99 Brazil Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 100 Brazil Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 101 Mexico Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 102 Mexico Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 103 Mexico Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 104 Mexico Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 105 Mexico Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 106 Rest of Latin America Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 107 Rest of Latin America Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 108 Rest of Latin America Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 109 Rest of Latin America Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 110 Rest of Latin America Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 111 Middle East and Africa Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 112 Middle East and Africa Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 113 Middle East and Africa Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 114 Middle East and Africa Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 115 Middle East and Africa Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 116 GCC Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 117 GCC Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 118 GCC Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 119 GCC Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 120 GCC Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 121 Africa Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 122 Africa Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 123 Africa Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 124 Africa Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 125 Africa Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 126 Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 127 Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 128 Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 129 Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 130 Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Platelet Rich Plasma (PRP) Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Platelet Rich Plasma (PRP) Market: Quality Assurance
  • FIG. 5 Global Platelet Rich Plasma (PRP) Market, By Type, 2022
  • FIG. 6 Global Platelet Rich Plasma (PRP) Market, By Application, 2022
  • FIG. 7 Global Platelet Rich Plasma (PRP) Market, By End-use, 2022
  • FIG. 8 Global Platelet Rich Plasma (PRP) Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Platelet Rich Plasma (PRP) Market, 2022
  • FIG. 10 Market Positioning of Key Platelet Rich Plasma (PRP) Market Players, 2022
  • FIG. 11 Global Platelet Rich Plasma (PRP) Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 12 Global Platelet Rich Plasma (PRP) Market, By Type, 2022 Vs 2031, %
  • FIG. 13 Global Platelet Rich Plasma (PRP) Market, By Application, 2022 Vs 2031, %
  • FIG. 14 Global Platelet Rich Plasma (PRP) Market, By End-use, 2022 Vs 2031, %
  • FIG. 15 U.S. Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 22 France Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 24 China Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 26 India Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031